Seaview Trust 13D and 13G filings for Allogene Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-14 5:20 pm Sale | 2021-12-31 | 13G | Allogene Therapeutics, Inc. ALLO | Seaview Trust | 7,041,120 4.940% | -299,747 (-4.08%) | Filing |
| 2021-02-12 1:00 pm Sale | 2020-12-31 | 13G | Allogene Therapeutics, Inc. ALLO | Seaview Trust | 7,340,867 5.200% | -1,251,741 (-14.57%) | Filing |